1. Home
  2. TFX vs BILI Comparison

TFX vs BILI Comparison

Compare TFX & BILI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFX
  • BILI
  • Stock Information
  • Founded
  • TFX 1943
  • BILI 2009
  • Country
  • TFX United States
  • BILI China
  • Employees
  • TFX N/A
  • BILI N/A
  • Industry
  • TFX Medical/Dental Instruments
  • BILI EDP Services
  • Sector
  • TFX Health Care
  • BILI Technology
  • Exchange
  • TFX Nasdaq
  • BILI Nasdaq
  • Market Cap
  • TFX 5.9B
  • BILI N/A
  • IPO Year
  • TFX N/A
  • BILI 2018
  • Fundamental
  • Price
  • TFX $126.22
  • BILI $17.89
  • Analyst Decision
  • TFX Hold
  • BILI Strong Buy
  • Analyst Count
  • TFX 10
  • BILI 9
  • Target Price
  • TFX $176.50
  • BILI $20.59
  • AVG Volume (30 Days)
  • TFX 717.4K
  • BILI 3.1M
  • Earning Date
  • TFX 05-01-2025
  • BILI 05-20-2025
  • Dividend Yield
  • TFX 1.08%
  • BILI N/A
  • EPS Growth
  • TFX N/A
  • BILI N/A
  • EPS
  • TFX 3.20
  • BILI N/A
  • Revenue
  • TFX $3,010,144,000.00
  • BILI $3,676,004,571.00
  • Revenue This Year
  • TFX $1.40
  • BILI $15.20
  • Revenue Next Year
  • TFX $4.85
  • BILI $8.73
  • P/E Ratio
  • TFX $39.45
  • BILI N/A
  • Revenue Growth
  • TFX 0.29
  • BILI 19.10
  • 52 Week Low
  • TFX $121.70
  • BILI $10.84
  • 52 Week High
  • TFX $249.91
  • BILI $31.77
  • Technical
  • Relative Strength Index (RSI)
  • TFX 42.23
  • BILI 50.94
  • Support Level
  • TFX $120.06
  • BILI $17.51
  • Resistance Level
  • TFX $138.93
  • BILI $18.71
  • Average True Range (ATR)
  • TFX 3.84
  • BILI 0.43
  • MACD
  • TFX -0.49
  • BILI 0.22
  • Stochastic Oscillator
  • TFX 32.64
  • BILI 71.55

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Share on Social Networks: